Notably, the new G3 category has been described with Ki-67 > 20% and well-differentiated morphology, in contrast to neuroendocrine carcinomas (NECs) with Ki-67 > 20% and poor differentiation [3]. Here, MKI67 is linked to neuroendocrine carcinoma.